Bayer AG — China registrations and re-registration filing lines
34 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest filing line: 2026-10-07.
| Approval number | Product | Certificate expires | Filing line (Art. 82) |
|---|---|---|---|
| 国药准字HJ20220032 | VITRAKVI 硫酸拉罗替尼胶囊 | 2027-04-07 | 2026-10-07 |
| 国药准字HJ20220033 | VITRAKVI 硫酸拉罗替尼胶囊 | 2027-04-07 | 2026-10-07 |
| 国药准字HJ20181081 | Xarelto 利伐沙班片 | 2027-04-26 | 2026-10-26 |
| 国药准字HJ20181082 | Xarelto 利伐沙班片 | 2027-04-26 | 2026-10-26 |
| 国药准字HJ20181083 | Xarelto 利伐沙班片 | 2027-04-26 | 2026-10-26 |
| 国药准字HJ20220050 | Verquvo 维立西呱片 | 2027-05-17 | 2026-11-17 |
| 国药准字HJ20220051 | Verquvo 维立西呱片 | 2027-05-17 | 2026-11-17 |
| 国药准字HJ20220052 | Verquvo 维立西呱片 | 2027-05-17 | 2026-11-17 |
| 国药准字HJ20220056 | Larotrectinib Sulfate Oral Solution 硫酸拉罗替尼口服溶液 | 2027-06-22 | 2026-12-22 |
| 国药准字HJ20220057 | Kerendia 非奈利酮片 | 2027-06-27 | 2026-12-27 |
| 国药准字HJ20220058 | Kerendia 非奈利酮片 | 2027-06-27 | 2026-12-27 |
| 国药准字HJ20171341 | Adalat 硝苯地平控释片 | 2027-08-04 | 2027-02-04 |
| 国药准字HJ20171342 | Adalat 硝苯地平控释片 | 2027-08-04 | 2027-02-04 |
| 国药准字SJ20235001 | Eylea 阿柏西普眼内注射溶液 | 2028-01-11 | 2027-07-11 |
| 国药准字SJ20180010 | Eylea 阿柏西普眼内注射溶液 | 2028-04-09 | 2027-10-09 |
| 国药准字SJ20255004 | EYLEA 阿柏西普眼内注射溶液 | 2028-04-09 | 2027-10-09 |
| 国药准字HJ20140939 | Ventavis 吸入用伊洛前列素溶液 | 2028-04-24 | 2027-10-24 |
| 国药准字HJ20140940 | Ventavis 吸入用伊洛前列素溶液 | 2028-04-24 | 2027-10-24 |
| 国药准字HJ20140941 | Ventavis 吸入用伊洛前列素溶液 | 2028-04-24 | 2027-10-24 |
| 国药准字SJ20130094 | Betaferon 注射用重组人干扰素β-1b | 2028-08-23 | 2028-02-23 |
| 国药准字HJ20181084 | Xarelto 利伐沙班片 | 2028-11-29 | 2028-05-29 |
| 国药准字HJ20181085 | Xarelto 利伐沙班片 | 2028-11-29 | 2028-05-29 |
| 国药准字HJ20181086 | Xarelto 利伐沙班片 | 2028-11-29 | 2028-05-29 |
| 国药准字HJ20181087 | Xarelto 利伐沙班片 | 2028-11-29 | 2028-05-29 |
| 国药准字HJ20200032 | Radium[223Ra] chloride Injection 氯化镭[223Ra]注射液 | 2029-11-28 | 2029-05-28 |
| 国药准字HJ20160201 | Nexavar 甲苯磺酸索拉非尼片 | 2029-12-19 | 2029-06-19 |
| 国药准字HJ20200024 | Xarelto 利伐沙班片 | 2030-02-06 | 2029-08-06 |
| 国药准字HJ20171300 | Stivarga 瑞戈非尼片 | 2030-11-09 | 2030-05-09 |
| 国药准字HJ20260049 | Kerendia 非奈利酮片 | 2031-05-18 | 2030-11-18 |
| 国药准字HJ20170356 | Adempas 利奥西呱片 | 2031-06-03 | 2030-12-03 |
| 国药准字HJ20170357 | Adempas 利奥西呱片 | 2031-06-03 | 2030-12-03 |
| 国药准字HJ20170358 | Adempas 利奥西呱片 | 2031-06-03 | 2030-12-03 |
| 国药准字HJ20170359 | Adempas 利奥西呱片 | 2031-06-03 | 2030-12-03 |
| 国药准字HJ20170360 | Adempas 利奥西呱片 | 2031-06-03 | 2030-12-03 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.